期刊文献+

土木香中纯化的五种倍半萜类化合物抑制肿瘤增殖活性的研究 被引量:10

In vivo and in vitro anti-tumor activity studies of five sesquiterpenoids from Inula helenium
下载PDF
导出
摘要 目的检测土木香中纯化的五种倍半萜化合物抑制肿瘤增殖的活性,并探讨化合物结构与活性之间的关系。方法应用MTT法测定五种倍半萜类化合物对体外培养人肿瘤细胞增殖的影响;应用小鼠移植性肝癌模型测定了异土木香内酯的抗肿瘤活性。结果化合物1(异土木香内酯)对U251SP细胞、HLE细胞和MM1-CB细胞的增殖显示较强的抑制活性;化合物2~5对各种实验用肿瘤细胞的增殖不显示抑制活性;化合物1对移植性肿瘤(肝癌H22)具有明显的抑制作用,并呈现较好的剂量依赖关系。结论异土木香内酯具有较强的肿瘤抑制活性;化合物2~5对肿瘤细胞增殖抑制活性丧失可能由于A-环和B-环之间的键裂开,形成一个大10元环,改变了原来的构象所致。 Aim To detect the antitumor activities of five sesquiterpene lactones from the roots of Inula helenium. Method Using MTT assay to evaluate the anti-tumor activities of five sesquiterpene lactones to the cell lines of U251SP,T-98,HLE,MM1-CB,HMV-1 and KT,and to explore the relationship between structure and activities. Results Isoalantolactone exhibited significant anti-growth activities to U251SP,HLE and MM1-CB,while other compounds demonstrated weak or moderate anti-growth activities to cell lines even in the 50% inhibition concentration≤100 μmol·L-1. Con-clusion Isoalantolactone exhibits significant anti-growth activities to three cell lines and its anti-tumor activitiesve close relationship with the structures,α,β-unsaturated five-membered lactone ring is necessary for the activities,and saturated lactone or 5,10-seco and A,B-ring become a ten-membered macro-ring leading to the loss or decrease of anti-growth activity.
出处 《中国药理学通报》 CAS CSCD 北大核心 2010年第1期112-115,共4页 Chinese Pharmacological Bulletin
基金 河北省自然科学基金资助项目(No08B032) 河北省留学回国人员科技活动资助项目(No2006-02)
关键词 土木香 倍半萜类化合物 肿瘤细胞 移植性肿瘤 增殖活性 构效关系 Inula helenium sesquiterpenes human tumor cell lines transplanted tumor anti-growth activity structure-activity relationship
  • 相关文献

参考文献9

  • 1Konishi T, Shimada Y, Nagao T, et al. Antiproliferative sesquiterpene lactones from the roots of Inula helenium [ J ]. Biol Pharm Bull, 2002,25 : 1370 - 2.
  • 2Yang C, Wang C M, Jia Z J. Sesquiterpenes and other constituents from the aerial parts of Inula japonica[ J]. Planta Med,2003,69: 662 - 6.
  • 3杜德极,石小枫,冉长清,起军宁,温志坚,谢定成,叶玉兰,顾月翠.葛根的抗肿瘤作用研究[J].中药药理与临床,1994,10(2):16-20. 被引量:27
  • 4郑晓亮,刘雪莉,钱伯初.植物提取物诱导肿瘤细胞凋亡机制研究进展[J].中国药理学通报,2004,20(11):1201-1205. 被引量:16
  • 5Clardy J, Walsh C. Lessons from natural molecules [ J ]. Nature, 2004,432:829 - 37.
  • 6Shi Q W,Dong M,Huo C H,et al. New 17-hydroxy-taxane and 2, 20-epoxy-11 ( 15-1 ) abeotaxane from the needles of Taxus canadensin [ J]. Biosci Biotechnol Biochem,2007,71 (7) : 1777 - 80.
  • 7Altmann K H, Gertsch J. Antieaneer drags from nature-natural products as a unique source of new microtubule-stabilizing agents [ J ]. Nat Prod Rep ,2007,24:327 - 57.
  • 8Lee K H. Current developments in the discovery and design of new drug candidates from plant natural product teads[ J]. J Nat Prod, 2004,67 ( 2 ) : 273 - 83.
  • 9Saklani A, Kutty S K. Plant-derived compounds in elinieal trials [ J ]. Drug Discov Today,2008,13 ( 3 - 4 ) : 161 - 71.

二级参考文献28

  • 1赵军宁,温志坚.体视学方法及其在中药药理研究中的应用[J].中药药理与临床,1991,7(3):43-46. 被引量:4
  • 2杜德极,石小枫,冉长清,谢定成,曾庆田.复方菝葜抗炎、抗肿瘤及毒性研究[J].中成药,1989,11(12):29-31. 被引量:19
  • 3Stadheim TA,Xiao H,Eastman A.Inhibition of extracellular signal-regulated kinase(ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells[J].Cancer Res,2001,61(4):1533-40.
  • 4Fan M,Goodwin ME,Birrer MJ,Chambers TC.The c-Jun NH2-terminal plrotein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine[J].Cancer Res,2001,61(11):4450-8.
  • 5Kruczynski A,Etiévant C,Perrin D et al.Characterization of cell death induced by vinflunine,the most recent vinca alkaloid in clinical development[J]. Br J Cancer,2002,86(1):143-50.
  • 6Shao RG,Cao CX,Nieves-Neira W et al.Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells[J]. Oncogene,2001,20P (15): 1852-9.
  • 7Chatterjee D,Schmitz I,Krueger A et al.Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP (short)[J].Cancer Res,2001,61(19):7148-54.
  • 8Reinhold WC,Kouros-Mehr H,Kohn KW et al.Apoptotic susceptibility of cancer cells selected for camptothecin resistance:gene expression profiling,functional analysis,and molecular interaction mapping[J]. Cancer Res,2003,63(5):1000-11.
  • 9Nakashio A,Fujita N,Rokudai S et al.Prevention of phosphatidylinositol 3′-kinase-Akt survival signaling pathway during topotecan-induced apoptosis[J]. Cancer Res,2000,60(18):5303-9.
  • 10Zhang XW,Xu B.Differential regulation of p53,c-Myc,Bcl-2,Bax and AFP protein expression,and caspase activity during 10-hydroxy-camptothecin-induced apoptosis in Hep G2 cells[J].Anticancer Drugs,2000,11(9):747-56.

共引文献41

同被引文献59

引证文献10

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部